Day of Life Sciences
11th Day of Life Sciences hosts Hydroxyanthracene Derivatives Symposium
Analysis, Safety, Quality and Efficacy in Herbal Medicinal Products
This year’s ICBT Day of Life Sciences is taking place on April 11th 2019. It's organised by the Phytopharmacy and Natural Product Research Group is dedicated to the Hydoxyanthracene Derivatives – a topic specially selected on the occasion of the 70th birthday of Prof. Beat Meier for honouring his outstanding scientific achievements in phytochemical analysis for the European Pharmacopoeia and the Swiss Pharmacopoeia as well as for various industrial applications.
The Hydroxyanthracene Derivatives Symposium will feature cutting-edge contributions about analysis, quality, safety and efficacy of this interesting phytochemical substance class. It will also provide a platform for dialogue and scientific knowledge transfer for participants from industry, regulatory bodies, academia or education.
Confirmed speakers
- Prof. Dr. Salvador Cañigueral, University of Barcelona (ES)
- Prof. Dr. Rudolf Bauer, University of Graz (A)
- Dr. Tobias Gosdschan, Swissmedic (CH)
- Prof. Dr. Werner Knoess, Federal Institute of Drugs and Medical Devices (D)
- Prof. Dr. Beat Meier, Swiss Medical Society of Phytotherapie (CH)
- Nadja Meier, ZHAW (CH)
- Dr. Herbert Schwabl, Padma AG (CH)
- Alexander Schenk, Max Zeller Söhne AG (CH)
- Prof. emer. Dr. Johannes Westendorf, Formerly Univ. Hamburg (D)
Call for posters – Abstracts for poster presentations linked with the topic of hydroxyanthracene derivatives are welcome and should be submitted by using this template (DOC 144,2 KB) until February 15th, 2019. Email: piha@zhaw.ch
Scientific Lead – Dr. Evelyn Wolfram, Head of Phytopharmacy and Natural Products Research Group, Institute of Chemistry and Biotechnology, Zurich University of Applied Sciences, Wädenswil (CH)
Review
2018 - Second Symposium of Industrial Biocatalysis
The Second Symposium of Industrial Biocatalysis hosted speakers from Switzerland and abroad who talked about current challenges in the field.
Flyer «First Network Meeting Innovation in Biocatalysis - June 6th» (PDF 302,2 KB)
Flyer «Second Symposium of Industrial Biocatalysis - June 7th» (PDF 442,2 KB)
2017 - ICBT: Factories of the future
What will the future bring? Our students will design them. That's why, together with our partners from industry and research, we are already developing the latest technologies that map the production processes of tomorrow. Amongst others, we present techniques such as flow chemistry, microreactor technology and 3D printing for personalized implants and entire fabrics.
2016 - Industrial Biocatalysis
Biocatalysis enables the sustainable production of chiral and highly functionalized compounds for the chemical and pharmaceutical industry. The Competence Centre of Biocatalysis at the ZHAW promotes biocatalysis as a complementary method to classic organic synthesis. It aims to help bridge the gap between academic laboratories and the production plant.
2015 - Frontiers in Personalized Medicine
A Precision Medicine initiative in the USA, announced by President Obama in January 2015, is designed to promote wider use of patient-specific medical care. The aim is to deliver new and more effective treatments for diseases. But what is going on in this ambitious, challenging field in Switzerland and in Europe?
Flyer: detailed information and agenda (PDF 428,1 KB)
Download speeches
Current and future trends in personalized medicine, (PDF 3,5 MB)Dr. Bruce Jordan, Roche Diagnostics
International Ltd Challenges of personalized health for clinical medicine (PDF 2,5 MB), Prof. Dr. Peter Meier-Abt, Swiss Academy of Medical Sciences, Basel
Implementing research in personalized medicine (PDF 1,8 MB), Prof. Dr. Niko Beerenwinkel, ETH Zurich, Competence Center Personalized Medicine
Osteosarcoma: Current perspectives and future development (PDF 7,3 MB), Prof. Dr. Bruno Fuchs, Sarcoma Center UZH, University Hospital Balgrist
Gene therapy in ophthalmology – the TargetAMD project (PDF 2,1 MB), Dr. Martina Kropp, University Hospital Geneva
TEDD information (PDF 1,7 MB), Prof. Dr. Ursula Graf-Hausner, Zurich University of Applied
2014 - Neue Materialien aus Holz – nahe oder ferne Zukunft?
In der Verwendung von Holz als Baustein für chemische Produkte und zur Herstellung neuartiger Verbundstoffe liegt ein grosses Potenzial für die Ablösung der global noch stark erdölbasierten Materialwirtschaft. Der 6. Chemietag der ZHAW widmet sich den vielfältigen wissenschaftlichen und unternehmerischen Herausforderungen, die sich in der Forschung und Entwicklung innovativer holzbasierter Materialien aktuell stellen.
Flyer: Informationen und Programm (PDF 463,1 KB)
Download Referate
Aktivitäten am Institut für Chemie und Biologische Chemie, (PDF 2,2 MB) Prof. Dr. Christian Hinderling, Institutsleiter ICBC, ZHAW, Wädenswil
Innovations-Suchfelder für holzbasierte Materialien, (PDF 2,2 MB)Dr. Willi Schwotzer, Psetta GmbH, Neuenkirch
Polymere Nanoverbundswerkstoffe mit Zellulose Nanofasern (PDF 6,1 MB), Prof. Dr. Christoph Weder, Adolphe Merkle Institut, Marly
Holz als Chemierohstoff: Extraktion von Tanninen aus Rinden heimischer Nadelhölzer (PDF 1,4 MB), Dr. Frédéric Pichelin, Berner Fachhochschule, Biel
Wasserfeste, dimensionsstabile LVL aus Buchenholz (PDF 2,2 MB), Prof. Dr. Holger Militz, Georg-August-Universität, Göttingen
Bio-inspirierte Materialien aus Holz (PDF 1,8 MB), Prof. Dr. Ingo Bugert, ETH Zürich
2013 - Didaktik in der Chemie
Im Fokus dieser Veranstaltung stehen aktuelle didaktische Herausforderungen im Unterricht an Berufs- und Fachhochschulen. Diese tragen zum Erfolg des dualen Bildungssystems in der Schweiz bei. Zudem hat die Bologna-Reform zu einer Internationalisierung beigetragen, die ein länderübergreifendes Qualitätsmanagement nötig erscheinen lässt (Eurobachelor).
Flyer: Informationen und Programm (PDF 195,7 KB)
Medienmitteilung (PDF 52,0 KB)
Download Referate
2012 - Solar Energy - Chemical Solutions
Sunlight is the most abundant and reliable source of energy available to humanity. In order to provide a truly widespread primary energy source, solar energy must be harvested, converted, and stored in a cost-effective manner. These three key steps require scientific and technological breakthroughs. Chemistry contributes to this development by creating new materials for capturing sunlight, converting light to electricity, enabling light-driven reactions, or increasing the long-term stability of solar cells.
Flyer: detailed information and agenda (PDF 525,0 KB)
Download speeches (slides)
Photovoltaics in Switzerland - the cycle of research, technology, industry and markets (PDF 3,4 MB), Dr. Stefan Nowak, Programme Manager, Swiss Photovoltaic Research Programme, Swiss Federal Office of Energy
Modeling and simulation of photoelectrochemical cells (PDF 2,5 MB), Dr. Matthias Schmid, ZHAW
New trends in organic materials based solar cells (PDF 3,9 MB), Prof. Dr. Frank Nüesch, EMPA
Running chemical reactions at ultra-high temperatures for solar energy storage - potential and challenges (PDF 10,2 MB), Dr. Ivo Alxneit, Solar Technology Laboratory, PSI
2011 - Medicinal Chemistry
The pharmaceutical industry is of global economic importance. As a central component, drug development is a complex process that requires interdisciplinary research and development. Only the effective collaboration of different scientific disciplines enables the development of new medicines for the benefit of patients.
Flyer: information and programme (PDF 2,2 MB)
Download speeches (slides)
Drug discovery in the academic setting (PDF 6,0 MB) (Rainer Riedl, ZHAW)
VIBRANT a European Project for Betacell Imaging and Quantification (PDF 5,4 MB) (Theo Schotten, CAN GmbH)
Blocking AMRE - Chemistry and Biochemistry at a Nasty Enzyme (PDF 1,3 MB) (Andreas Natsch, Fridtof Schröder, Givaudan Schweiz AG)
VirtualToxLab TM - In silico prediction of the toxic potential of drugs and chemicals (PDF 3,0 MB) (Angelo Vedani, Department of Pharmaceutical Sciences, University of Basel)
Discovery of the Novel, Orally Active S1P Receptor Agonist ACT-128800 (Ponesimod) (PDF 3,7 MB) (Martin Bolli, Actelion Pharmaceuticals Ltd)